0001513162-19-000091.txt : 20190409 0001513162-19-000091.hdr.sgml : 20190409 20190409161515 ACCESSION NUMBER: 0001513162-19-000091 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190405 ITEM INFORMATION: Other Events FILED AS OF DATE: 20190409 DATE AS OF CHANGE: 20190409 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMERICA INC CENTRAL INDEX KEY: 0000073290 STANDARD INDUSTRIAL CLASSIFICATION: DENTAL EQUIPMENT & SUPPLIES [3843] IRS NUMBER: 952645573 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37863 FILM NUMBER: 19739620 BUSINESS ADDRESS: STREET 1: 17571 VON KARMAN AVENUE CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 9496452111 MAIL ADDRESS: STREET 1: 17571 VON KARMAN AVENUE CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: NMS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19871130 FORMER COMPANY: FORMER CONFORMED NAME: NUCLEAR MEDICAL SYSTEMS INC DATE OF NAME CHANGE: 19830216 FORMER COMPANY: FORMER CONFORMED NAME: NUCLEAR INSTRUMENTS INC DATE OF NAME CHANGE: 19720508 8-K 1 form8k.htm FORM 8-K Form 8-K

SECURITIES AND EXCHANGE COMMISSION


WASHINGTON, D.C.


FORM 8-K


CURRENT REPORT



Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934


 April 5, 2019

Date of Report (date of earliest event reported)

 

BIOMERICA, INC.

(Exact Name of Registrant as Specified in its Charter)



Delaware

0-8765

95-2645573

(State or Other Jurisdiction of Incorporation)

 (Commission File Number) (IRS Employer Identification Number)


17571 Von Karman Ave.

Irvine, California 92614

(Address of Principal Executive Offices

Including Zip Code)



949-645-2111

(Registrant’s Telephone Number,

Including Area Code)


______________

(Former Name or Former Address if Changed

Since Last Report)


Page 1 of 2 pages





Item 8.01  Other Events


Biomerica, Inc., has announced that the United States Patent and Trademark Office (“USPTO”) has issued a Notice of Allowance for the Company’s InFoods® Irritable Bowel Syndrome (“IBS”) product. This allowed application (#15/526,240) contains numerous claims that cover a product that enables physicians to identify patient specific foods that when removed from the diet may alleviate or improve an individual’s IBS symptoms.


Following a Notice of Allowance, the process resulting in final issuance of a patent involves several administrative steps that are typically completed within a year.



     








SIGNATURES


     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Dated:  April 9, 2019

                        Biomerica, Inc.


            By: /s/ Zackary S. Irani

Zackary S. Irani

Chief Executive Officer